Nursing care
Hepatic Encephalopathy nursing care: what to assess and what to do first
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Hepatic encephalopathy is a decline in brain function caused by the liver's failure to clear ammonia and other neurotoxins from the blood. Asterixis, the flapping tremor, is the earliest reliable sign. Nursing priorities are frequent neuro checks, ammonia-reducing therapy with lactulose titrated to 2-3 soft stools a day, and airway protection as the grade worsens.
The pathophysiology in one pass
A damaged or cirrhotic liver cannot metabolise ammonia produced by gut bacteria breaking down protein. Ammonia bypasses hepatic clearance, often through portosystemic shunts or collateral vessels that form as portal pressure rises, and crosses the blood-brain barrier. Once there it disrupts astrocyte function and neurotransmission, producing the spectrum of confusion, personality change, and eventually coma that defines hepatic encephalopathy.
Ammonia is the main driver but not the only one. GABA-ergic tone increases, and other gut-derived toxins contribute, which is why the condition can flare with any event that raises nitrogen load or reduces clearance further: a GI bleed, constipation, dehydration, infection, sedatives metabolised by the liver, or a new diuretic causing hypokalaemia. Recognising these precipitants matters more than memorising the biochemistry, because most cases are triggered by something reversible.
Assessment findings that matter
Asterixis is the early sign. Ask the patient to extend the arms and dorsiflex the wrists; a rhythmic flap indicates metabolic encephalopathy before the patient looks obviously confused on a bedside conversation. Check it every shift in an at-risk patient, not just when mentation seems off, because subtle grade 1 changes are easy to miss in someone who is still verbal and oriented to person.
Beyond asterixis, track the trajectory using a grading scale: mild confusion and reversed sleep-wake pattern (grade 1), lethargy and disorientation (grade 2), marked confusion with somnolence but rousable (grade 3), and coma (grade 4). Fetor hepaticus, a sweet musty breath odour, often accompanies rising ammonia. Serial documentation of orientation, handwriting or a number-connection test if the patient can cooperate, and pupil and gag response as grade rises all belong in the chart, because a single normal exam tells you nothing about direction of travel.
What the exam asks about this
NCLEX-style items on hepatic encephalopathy usually hinge on two things: recognising asterixis as the earliest finding rather than jumping to confusion, and correctly prioritising lactulose administration and titration over other orders. Expect a question that gives a patient with mild personality change and normal ammonia level and asks what to check first — the answer is asterixis, not a lab value, because the exam is testing bedside assessment over waiting on results.
A second common pattern tests dose titration logic: a stem states the patient has had one soft stool today and asks what to do, and the correct answer is to increase the lactulose dose, not withhold it, because the therapeutic endpoint is 2-3 stools a day. Distractor answers often suggest holding the drug for loose stools or calling the provider about diarrhoea, both wrong unless the patient is having more than 3-4 watery stools with signs of volume depletion.
Nursing interventions in priority order
Protect the airway and prevent injury first, especially at grade 3 or above: position for aspiration precaution, keep the bed low with rails up, and reorient at every contact. Administer lactulose as ordered and titrate to the stated goal of 2-3 soft stools a day; more frequent stooling within that target range means the drug is working, not a side effect to report or treat. Hold or reduce the dose only if the patient develops signs of volume depletion or electrolyte loss from true hyperdefecation.
Restrict protein only as directed and only short-term in acute flares; current practice favours adequate protein intake with plant or dairy sources over prolonged restriction, since malnutrition worsens outcomes in cirrhosis. Correct precipitants actively: treat constipation, screen for and treat infection, correct hypokalaemia, and review the medication list for sedatives or opioids that need to be held. Monitor fluid balance and avoid unnecessary diuresis that can trigger a flare through hypovolaemia and hypokalaemia.
Medications and monitoring
Lactulose is first-line: it acidifies the colon, converting ammonia to the non-absorbable ammonium ion and trapping it for excretion, while also acting as a laxative to clear nitrogenous waste. Titrate the dose to 2-3 soft stools daily and document stool count and consistency every shift rather than relying on the patient's recall. Rifaximin is commonly added for patients who cannot tolerate escalating lactulose or who have recurrent episodes, working by reducing ammonia-producing gut flora; it does not replace lactulose but is typically used alongside it.
Serum ammonia can support the diagnosis but correlates poorly with clinical severity, so treat the patient and the asterixis, not the number alone. Monitor electrolytes, renal function, and coagulation given the underlying liver disease, and reassess mentation and asterixis on a fixed schedule so any grade change is caught early rather than at the next physician round.
When to escalate
Escalate immediately for any drop in level of consciousness, loss of gag reflex, or progression to grade 3-4, since airway protection and possible intubation become the priority. Also escalate for signs of a precipitating GI bleed, new fever suggesting spontaneous bacterial peritonitis, or worsening renal function, all of which change the treatment plan beyond lactulose titration.
Call the provider if lactulose is not achieving the stool goal despite appropriate dose increases, if the patient becomes unsafe to swallow oral medication, or if asterixis and confusion worsen despite therapy. These are the points where the plan needs reassessment rather than continued observation.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our gastrointestinal practice questions are the closest set to what this page covers.
Common questions
How many stools a day is lactulose supposed to produce?
The therapeutic goal is 2-3 soft stools a day. If the patient is having more within that range, the dose is working correctly rather than causing harm, so do not withhold or reduce it unless the patient shows signs of volume depletion.
What is the earliest sign of hepatic encephalopathy?
Asterixis, the flapping tremor elicited by having the patient extend the arms and dorsiflex the wrists, is the earliest reliable bedside sign. It can appear before obvious confusion, so check for it in any at-risk patient even when they seem oriented.
Why does constipation make hepatic encephalopathy worse?
Stool retention increases the time nitrogenous waste and gut bacteria spend in the colon, raising ammonia production and absorption. Keeping bowel movements regular, which is exactly what lactulose is doing, reduces the ammonia load reaching the bloodstream.
Should protein intake be restricted in hepatic encephalopathy?
Not routinely. Current practice favours maintaining adequate protein, preferably from plant or dairy sources, because malnutrition worsens outcomes in cirrhosis. Restriction is reserved for short periods during acute flares and only as directed.
Does the serum ammonia level tell you how sick the patient is?
Not reliably. Ammonia levels correlate poorly with clinical grade, so a normal level does not rule out encephalopathy and a high level does not confirm severity. Asterixis and mental status trends are better guides to the patient's actual condition.